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Abstract
The molecular mechanisms governing normal neurodevelopment are tightly regulated by the action of tran-
scription factors. Repressor element 1 (RE1) silencing transcription factor (REST) is widely documented as a
regulator of neurogenesis that acts by recruiting corepressor proteins and repressing neuronal gene expres-
sion in non-neuronal cells. The REST corepressor 1 (CoREST1), CoREST2, and CoREST3 are best described
for their role as part of the REST complex. However, recent evidence has shown the proteins have the ability
to repress expression of distinct target genes in a REST-independent manner. These findings indicate that
each CoREST paralogue may have distinct and critical roles in regulating neurodevelopment and are more
than simply “REST corepressors,” whereby they act as independent repressors orchestrating biological proc-
esses during neurodevelopment.
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Significance Statement
The molecular mechanisms governing normal development of the brain are yet to be fully elucidated. The
regulation of gene expression by transcription factors plays a significant role in the specification and matu-
ration of neurons and glia. Repressor element 1 (RE1) silencing transcription factor (REST) has been well
characterized as a transcriptional regulator of neurogenesis through the formation of a complex with the
REST corepressor (CoREST) proteins. Recently, the CoREST protein family has been shown to independ-
ently target unique genes, have distinct expression patterns, and important REST-independent functions
during neurodevelopment. Understanding the molecular mechanisms governed by the CoREST family will
provide insight into the regulatory networks directing normal neurodevelopment.
Introduction
Understanding the complex molecular mechanisms
regulating gene expression in the brain is integral in pro-
viding insight into the processes that govern normal de-
velopment, and conversely, are disrupted in neurologic
diseases. The precise and tightly regulated differentiation
of stem cells during embryogenesis and neurogenesis is
essential for cells, tissues and organs to form and function
properly. Transcription factors play an important role in
regulating both pluripotency and cell differentiation by
controlling expression patterns of genes critical for devel-
opment (Boyer et al., 2005). One transcription factor that
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governs pluripotency and cell fate is repressor element 1
(RE1) silencing transcription factor (REST; also known
as neuron restrictive silencer factor, NRSF). Through re-
pressing the expression of target genes, REST regulates
neurogenesis, neuronal differentiation and maturation
(Paquette et al., 2000; Ballas et al., 2005; Gupta et al.,
2009; Gao et al., 2011; Mandel et al., 2011), in addition to
a playing role in neuroprotection (Lu et al., 2014; Song et
al., 2016, 2017a). Dysfunction of REST and its corepres-
sor proteins are hypothesized to cause disruption in gene
regulatory networks, contributing to the pathophysiology
of neurodegenerative conditions, including Alzheimer’s
disease (AD; Lu et al., 2014; Ashton et al., 2017; Meyer et
al., 2019), Huntington’s disease (HD; Zuccato et al., 2003,
2007; Conforti et al., 2013), Parkinson’s (Suo et al., 2015;
Huang et al., 2019; Kawamura et al., 2019), and Prion dis-
ease (Song et al., 2016, 2017a,b).
Genome wide analysis revealed ;2000 potential
REST targets genes in the human genome (Bruce et al.,
2004; Johnson et al., 2006). REST represses transcrip-
tion by forming a complex with the REST corepressor 1
(CoREST1) and recruiting chromatin modifying enzymes
to induce a condensed chromatin state. Two pa-
ralogues, CoREST2 or CoREST3, have also been shown
to form a complex with REST (McGann et al., 2014;
Jung et al., 2018). However, the importance of the
CoREST proteins is only just emerging, as evidence
suggests they have the ability to target unique genes, in
a REST-independent manner, in various neural and glial
cell types at different stages of development (Abrajano
et al., 2009a, b; Wu et al., 2018). The expression profile,
regulatory networks and function of the CoREST family
in neurodevelopment is only partially defined. In this re-
view we discuss what is currently understood about the
role of the CoREST family in neurodevelopment and
how these proteins have a broader spectrum than acting
solely as “REST corepressors.”
REST
REST was initially discovered in 1995 as an integral
component of the central nervous system through its role
as a master negative regulator of neuronal gene expres-
sion (Chong et al., 1995; Schoenherr and Anderson,
1995). REST is a member of the Kruppel-type zinc finger
transcription factor family, containing eight GL1 Kruppel
zinc fingers in the DNA binding domain (Chong et al.,
1995; Palm et al., 1999). The binding domain allows REST
to bind to its target genes through the highly conserved
21 base pair DNA sequence motif, known as the RE1 site
(Chong et al., 1995; Schoenherr and Anderson, 1995).
Chromatin immunoprecipitation-coupled with deep se-
quencing (ChIP-seq) experiments have identified REST to
bind with ;2000 genes within the human genome (Satoh
et al., 2013; Rockowitz and Zheng, 2015) and 308 genes
in neurons derived from human embryonic stem cells
(ESCs) unique to the targets observed in ESCs (Satoh et
al., 2013). Although the RE1 site is observed within a wide
range of genes, it remains unclear whether REST interacts
and represses expression at these sites in vivo.
Role of REST in neurogenesis, neuroprotection, and
neurodegeneration
REST is an important regulatory factor within the devel-
oping nervous system through repressing transcription of
genes associated with neuronal differentiation and matu-
ration (Tabuchi et al., 2002; Bruce et al., 2004; Ballas et
al., 2005). Through the repression of neuronal genes
REST regulates the switch between precursor cell specifi-
cation and differentiation, with REST expression decreas-
ing with development allowing for neuronal maturation
(Su et al., 2004; Gao et al., 2011; Kim et al., 2015;
Nechiporuk et al., 2016). REST mediated gene suppres-
sion is facilitated by the recruitment of two corepressor
complexes, mammalian Swi-independent 3 (mSin3) and
CoREST, that allow for the binding of chromatin-modify-
ing enzymes (Ballas et al., 2005; Inui et al., 2017). In addi-
tion to its initial role in repressing neuronal genes in non-
neuronal cells such as Scn2a2 (encodes for NaV1.2),
Stmn2, Tubb3 (N-tubulin), Grm2 (also known as GluR2),
Bdnf, and Calb1 (calbindin; Armisén et al., 2002; Kuwabara
et al., 2004; Ballas et al., 2005), REST and its corepressor
proteins have also been implicated in the regulation of
other aspects of neurogenesis. For example, REST has
been described to regulate phenotypic switches be-
tween neuronal subtypes, whereby increased levels of
REST downregulate Gad1 (encoding for GAD67) and re-
duce PV-positive GABAergic interneurons in mice (Singh et
al., 2019). REST is also responsible for somatosensory
neuronal remodeling in pain states, with genetic deletion of
Rest in mice effectively preventing hyperalgesia (Zhang et
al., 2019). REST regulates synaptic plasticity in the rat hip-
pocampus through the timely developmental switch in syn-
aptic NMDA receptors (NMDARs) through the repression
of Grin2b, thus promoting NMDARs primarily composed of
GluN2A subunits (Rodenas-Ruano et al., 2012). Other
studies also provide evidence that REST plays a role in reg-
ulating the signaling cascades from neuronal insult to cell
death. Under ischemic conditions REST levels are upregu-
lated resulting in the suppression of GluR2 expression
altering calcium permeability of CA1 neurons in the hippo-
campus thus hypothesized to affect influence neuronal sur-
vival (Calderone et al., 2003). Collectively, these studies
have shown that the physiological role of REST is not only
the repression of neuronal genes in non-neuronal cells but
also governs broader aspects of neurogenesis and mainte-
nance of mature neurons including regulating synaptic
plasticity, neuronal remodeling and cell death.
REST also plays a role in neuroprotection, with aberrant
expression or altered subcellular localization associated
with a range of neurodegenerative diseases. In AD, there
has been shown to be a decrease in REST expression in
human cortical and hippocampal postmortem tissue. This
finding was accompanied by a loss of nuclear REST and
an upregulation of genes involved in cell death, Alzheimer’s
pathology and an accelerated differentiation of neural pro-
genitors (Lu et al., 2014; Meyer et al., 2019). In addition, a
decline in REST plasma levels was associated with in-
creasing severity of risk and impairment in patients with
mild cognitive impairment and AD (Ashton et al., 2017).
REST has been implicated in HD as mutant Huntingtin
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protein cannot sequester REST in the cytoplasm, leading
to an increase in nuclear REST in striatal neurons and the
repression of the REST target gene BDNF, contributing to
an increased susceptibility to neuronal cell death (Zuccato
et al., 2003, 2007; Conforti et al., 2013). REST was also
shown to be an essential mediator of the neuroprotective
function of the histone deacetylase (HDAC) inhibitor tri-
chostatin A (TSA) Parkinson’s disease mouse model, as
REST-deficient mice treated with TSA showed no improve-
ment in dopaminergic neurotoxicity, TH and striatal BDNF
levels and motor ability (Suo et al., 2015; Huang et al.,
2019). The authors suggest that this effect is due to REST
knock-out reducing adult neurogenesis and neural stem
cell (NSC) survival (Huang et al., 2019). In human postmor-
tem tissue, there is a loss of nuclear REST in aged dopami-
nergic neurons in Parkinson’s disease patients and an
increased accumulation of REST in Lewy bodies and pale
bodies, suggesting its sequestration in aggregates may di-
minish neuroprotective signaling (Kawamura et al., 2019).
In an infectious model of Prion disease in hamsters and in
vitro cell models, REST expression decreased and there
was loss of nuclear REST. Overexpression of REST pro-
tected against the neurotoxic peptide PrP106-126, in-
duced neuronal oxidative stress, mitochondrial damage,
synaptic dysfunction, and neurofibrillary degeneration, po-
tentially through the action of the Akt-mTOR and Wnt-
b -catenin signaling pathways (Song et al., 2016, 2017a,b).
Taken together, it is evident that REST plays a critical role
in neurodevelopment, is required for normal aging and
neuroprotection of the brain and exhibits region-specific
and cell type-dependent effects in neurodegenerative
diseases.
REST-mediated gene repression
Chromatin is a complex critical for packaging DNA with-
in the nucleus of a cell. The base unit of chromatin is a nu-
cleosome which is composed of eight histones that are
encircled by 147 base pairs of DNA. Histones have an un-
structured N-terminal tail that allows for the regulation
of transcription through changes in nucleosome-DNA in-
teractions. Gene expression is regulated by transcription
factors that activate or repress transcription through the
stepwise recruitment of chromatin-modifying enzymes.
Modifications of chromatin include acetylation (Allfrey et
al., 1964), methylation (Allfrey et al., 1964), phosphoryla-
tion (Wei et al., 1999), sumoylation (Shiio and Eisenman,
2003), and ubiquitination (Sun and Allis, 2002).
REST exerts its repressive effects on target gene expres-
sion through recruiting two separate corepressor com-
plexes, mSin3 and CoREST1 (formerly known as CoREST),
which in turn facilitate the binding of chromatin-modifying
enzymes (Ballas et al., 2005; Yu et al., 2011; Inui et al.,
2017). mSin3A or mSin3B bind to the N terminus of REST
and recruit HDAC1 and HDAC2 (Huang et al., 1999;
Naruse et al., 1999; Grimes et al., 2000). The C terminus of
REST binds the corepressor protein, CoREST1 (Barrios et
al., 2014). Two paralogues, CoREST2 and CoREST3, have
been found in humans and also form a complex with REST
(McGann et al., 2014; Jung et al., 2018). However, their
transcriptional activity and expression profile in the human
brain remains largely unknown (Barrios et al., 2014; Sáez et
al., 2015). Research suggests that each CoREST protein
may play a different role in neurodevelopment via targeting
unique genes in neural and glial cell types during develop-
ment (Abrajano et al., 2009a,b, 2010).
In the complex with REST, CoREST proteins recruit
complementary chromatin-modifying enzymes, including
lysine-specific histone demethylase 1A (LSD1; also
known as KDM1A), HDAC1/2, the H3K9 methyltransfer-
ase G9a, and the chromatin remodeling enzyme brahma-
related gene-1 (BRG1) to target genes in order to regulate
transcription (Battaglioli et al., 2002; Roopra et al., 2004;
Lee et al., 2005; Ooi et al., 2006). To induce a repressive
chromatin state, first BRG1 recognizes acetylated histone
4 lysine 8 (H4K8) and stabilizes REST binding to the RE1
site within target genes (Fig. 1A; Battaglioli et al., 2002).
HDAC1/2 then deacetylates H3K9 (Fig. 1B), allowing for
G9a to methylate H3K9 and LSD1 to demethylate mono-
methylated or dimethylated H3K4 (Fig. 1C; Tachibana et
al., 2001; Roopra et al., 2004; Shi et al., 2005). The re-
cruitment of heterochromatin protein 1 (HP1) and methyl
CpG-binding protein 2 (MeCP2) to the high-affinity site
of methylated H3K9 causes chromatin condensation and
thus represses gene expression (Fig. 1D; Lunyak et al.,
2002; Fuks et al., 2003). The stepwise activity of the
REST complex is integral in the regulation of neurodeve-
lopmental processes including neurogenesis (Gao et al.,
2011), neuronal differentiation and maturation (Kim et al.,
2015), synaptic plasticity (Rodenas-Ruano et al., 2012), and
neuroprotection (Lu et al., 2014; Song et al., 2017b).
Disruptions to REST-mediated gene repression are hy-
pothesized to result in the breakdown of these key neuro-
nal processes and contribute to the pathophysiology of
neurodegenerative conditions.
The CoREST Protein Family
The role of the CoREST family in neurodevelopment is
less understood than those of REST. However, studies
have indicated that CoREST proteins have distinct roles
in neurogenesis, neuronal differentiation and maturation
that are independent of REST. Despite their high se-
quence similarity in humans, evidence suggests each of
the CoREST family members elicits unique functions at
different stages of development (Yang et al., 2011; Wang
et al., 2016; Jung et al., 2018). While the CoREST proteins
appear to have independent roles, the exact function, tar-
get genes and expression pattern of each paralogue in
neural and glial cells remains to be precisely defined.
Biologically-relevant animal and cell-based models are
essential for defining the molecular function of CoREST
paralogues and providing insight into the mechanisms of
neurodevelopment. To date, several different models, in-
cluding rodent (Wang et al., 2016; Monaghan et al., 2017),
stem cell (Yang et al., 2011), and established cell lines
(Gómez et al., 2008), have been utilized to study the role
of CoREST proteins in development. The current under-
standing of the CoREST family expression profile, target
genes and functional roles in neurodevelopment are dis-
cussed in detail below.
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CoREST genes, transcripts, and protein structure
REST corepressor 1 (RCOR1) is a 12-exon gene located
on chromosome 14 that encodes CoREST1, a 53-kDa
protein composed of 485 amino acids (Andrés et al.,
1999). CoREST2 is a 58-kDa protein composed of 523
amino acids expressed by REST corepressor 2 (RCOR2)
which is a 13-exon gene located on chromosome 19
(Barrios et al., 2014). The final paralogue, CoREST3, is en-
coded by the 19-exon gene REST corepressor 3 (RCOR3)
located on chromosome 1, and is predicted to exist as
four different splice variants. The variants are 48-, 50-, 56-
, and 61-kDa proteins consisting of 436, 449, 495, and
553 amino acids, respectively (Barrios et al., 2014).
CoREST proteins interact with the REST complex via a
single zinc finger domain in the C-terminal half of REST
(Andrés et al., 1999). A single point mutation resulted in
abolished CoREST binding and transcriptional repression
by the complex (Andrés et al., 1999). The function of the
REST complex has been widely studied since discovery
in 1995, with less known about the CoREST complex.
Bioinformatics, structural analysis and immunoprecipita-
tion assays of the CoREST family has provided insight
into the components of the complex, how it interacts with
DNA and potential mechanisms of epigenetic modifica-
tions to regulate gene expression. Each CoREST protein
contains two Swi3, Ada2, N-CoR, TFIIIB (SANT) domains
hypothesized to have a role in histone tail recognition and
remodeling (Boyer et al., 2002, 2004; Lee et al., 2005; Shi
et al., 2005) and a single Egl-27 and MTA homology 2
(ELM2) domain that acts as a protein-binding and poten-
tially a DNA-binding site (Fig. 2; Solari et al., 1999; Lee et
al., 2005; Barrios et al., 2014). The ELM2 and SANT1 do-
mains are essential in recruiting HDAC1/2 (You et al.,
2001; Ding et al., 2003; Lee et al., 2005). A nonconserved
leucine at residue 165 in the SANT1 domain of CoREST2
results in impaired association with HDAC1/2 when com-
pared with the other paralogues (Fig. 2, dotted red line;
Barrios et al., 2014). The conserved linker domain be-
tween both SANT domains (Lee et al., 2005) or the SANT2
domain alone (Shi et al., 2005; Yang et al., 2006; Forneris
et al., 2007) is responsible for interacting with LSD1. The
SANT2 domain has been shown to mediate DNA binding
(Yang et al., 2006; Pilotto et al., 2015). The shortest
CoREST3 splice variant (isoform b; Fig. 2) only contains
the SANT1 and ELM2 domain, limiting its ability to form a
complex with LSD1, therefore reducing its transcriptional
repressive capacity, and in some instances, resulting in
the antagonism of CoREST1 (Barrios et al., 2014;
Upadhyay et al., 2014). CoREST1 and CoREST3 isoform
d are the only variants identified to have conserved
Figure 1. Schematic of REST-mediated gene repression. REST forms a complex with mSin3 (N-terminal) and CoREST (C-terminal)
that in turn recruit an array of chromatin modifying enzymes. A, Initially, REST binds to the RE1 site and is stabilized by the interac-
tion between BRG1 and acetylated H4K8. B, Following on, HDAC1/2 deacetylate H3K9. C, G9a methylates H3K9 and LSD1 deme-
thylates monomethylated or dimethylated H3K4. D, Finally, chromatin is condensed via the recruitment of HP1 and MeCP2 to the
high-affinity methylated H3K9, thus repressing gene expression.
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coiled-coil domains (Fig. 2, orange coil; Marchler-Bauer
et al., 2017; UniProt Consortium, 2018). Although the
CoREST proteins share high sequence similarity, it may
be their structural differences that result in a unique set of
target genes and distinct functions in various cell types
during neurodevelopment.
CoREST-mediated gene repression
CoREST proteins are best documented for their tran-
scriptional repression ability through their interaction with
REST, however, new evidence demonstrates that they
have the ability to repress unique target gene expression
in a REST-independent manner. The CoREST proteins
elicit their transcriptional repressive ability through the
formation of a complex constituted of LSD1 and the
HDACs HDAC1/2 in a 1:1:1 stoichiometry, known as the
LSD1-CoREST-HDAC (LCH) complex (Barrios et al., 2014;
Kalin et al., 2018). The significance of each CoREST pa-
ralogue during normal development remains a novel field,
with continued research certain to provide insight into the
regulatory mechanisms governing neurodevelopment.
The transcriptional activity of the LCH complex is medi-
ated by the synergistic effects of the HDAC and LSD1 en-
zymes (Kalin et al., 2018). The LCH complex binds to DNA
through the SANT2 domain of CoREST which displaces
the H3 tail (Yang et al., 2006; Pilotto et al., 2015). The DNA
binding of the complex allows the histone tail to be avail-
able to the active sites of the chromatin modifying en-
zymes. HDAC1/2 deacetylates multiple lysine residues
Figure 2. Structure of the CoREST proteins. Each CoREST paralogue contains an ELM2 domain and two SANT domains. The ELM2
and SANT1 domains are responsible for recruiting HDAC1/2. CoREST2 has a non-conserved leucine residue at 165 in the SANT1
domain resulting in impaired association with HDAC1/2. The linker domain between the SANT domains is responsible for binding
with LSD1. CoREST3 isoform b lacks a SANT2 domain, resulting in impaired LSD1 recruitment and is responsible for the antagonis-
tic action of the isoform. CoREST1 and CoREST3 isoform d both contain coiled-coil domains, represented by the orange coils.
Information collated via UniProt Consortium (2018) and Marchler-Bauer et al. (2017).
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(K9, K14, and K18) on H3 tail, while LSD1 demethylates
monomethylated or dimethylated H3K4 resulting in chro-
matin compaction and gene repression (Fig. 3; Pilotto et
al., 2015; Wu et al., 2018). The LCH demethylase activity
to H3K4 is significantly inhibited by H3K14 acetylation
(Wu et al., 2018). Therefore, epigenetic regulation medi-
ated by the LCH complex will be reduced when chromatin
is marked by acetylation at Lys14, leading to a diminished
repressive capacity towards genes that have an abun-
dance of acetylated H3K14 in their promoter or enhancer
region (Wu et al., 2018).
The variations in the CoREST protein structures are re-
sponsible for altered protein-protein interactions and
thus differences in transcriptional repressive capacity
(Barrios et al., 2014). Barrios and authors provide evi-
dence that all three paralogues behave as transcriptional
repressors through luciferase reporter assays. CoREST1
exhibited the highest transcriptional repressive capacity
of the three paralogues. Nucleosomal demethylation as-
says demonstrated LSD1 could demethylate dimethy-
lated H3K4 in free histones, but required CoREST1 for
the demethylation of nucleosomes (Upadhyay et al.,
2014). CoREST2 showed similar activity to CoREST1,
however with a reduced efficiency. The reduced repres-
sive activity of CoREST3 compared with CoREST1 was
not a result of diminished interaction with LSD1 but po-
tentially from a lower catalytic efficiency (Barrios et al.,
2014). In erythroid cells, the shortest isoform of CoREST3
did not facilitate nucleosomal demethylation, instead acted
as an antagonist competitively inhibiting CoREST1 activity
(Upadhyay et al., 2014). CoREST-mediated nucleosomal
demethylation was restored by appending the SANT2 do-
main from CoREST1 into CoREST3. The data suggests the
antagonistic and inhibitory function of CoREST3 stems
from the absence of the SANT2 domain observed in the
short isoform (Upadhyay et al., 2014). It also indicates that
the SANT2 domain is not only required for LSD1 recruit-
ment but additionally is crucial in mediating LCH com-
plex nucleosomal demethylation and thus is essential in
CoREST-mediated gene repression activity independ-
ent to REST. HDAC activity and coimmunoprecipitation
assays in vitro revealed CoREST2 to have reduced
association with HDAC1/2 when compared with its pa-
ralogues due to a non-conserved leucine residue at 165
in the SANT1 domain (Barrios et al., 2014). CoREST2
mutants that had leucine 165 modified to a serine had
similar repression activity as CoREST1 and CoREST3,
indicating that CoREST2 mediates transcriptional re-
pression in a HDAC-independent manner (Barrios et al.,
2014). All CoREST proteins were confirmed to interact
with all splice variants of LSD1 through coimmunoprecipi-
tation assays, suggestive of a highly adaptable LCH com-
plex (Sáez et al., 2015). Taken together, the versatility of
the LCH complex is indicative of a wide range of novel
gene targets that may be crucial in regulating neurodevel-
opment. There is a prominent void in the literature regard-
ing the differences in transcriptional repression potency
and activity between the REST-CoREST and the LCH com-
plex. Further research is required to confirm the formation
of the LCH complex in vivo, characterize the DNA se-
quence at the binding site of the complex and thereby
identify the gene targets for each CoREST protein.
Expression and subcellular distribution of the CoREST
proteins during neurodevelopment
Current literature is suggestive of distinct expression
profiles for each CoREST protein during neurodevelop-
ment and in the mature brain depending on the cell type
and developmental stage. The unique expression profile
of each paralogue is suggestive of the formation of multi-
ple LCH complexes, composed of a different CoREST
protein core, with the potential to target a broad spectrum
of target genes implicated in neurogenesis and neuronal
maturation. Research has largely been based on animal
studies, but provides valuable insight into the potential
regulatory roles and functions the CoREST family may be
involved in during neurodevelopment.
CoREST paralogues exhibit an age-dependent and re-
gion-specific expression pattern in the brain
Analysis of RNA-seq databases identified widespread
expression of all CoREST paralogues, including the four
splice variants of CoREST3 throughout rat adult brain tis-
sue (Sáez et al., 2015). Sáez et al. (2015) used two models
Figure 3. CoREST-mediated gene repression. CoREST forms a complex with HDAC1/2 and LSD1 to elicit transcriptional repres-
sion. A, CoREST binds to DNA sites through the SANT2 domain. HDAC1/2 deacetylates multiple acetylated lysine marks on the H3
tail. LSD1 demethylates monomethylated or dimethylated H3K4. B, The synergistic function of both chromatin modifying enzymes
results in chromatin condensation thus repression of gene expression.
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of differentiation, nerve-growth factor (NGF)-induced neu-
ronal differentiation of PC12 cells and in vitro maturation
of embryonic rat cortical neurons to document changes
in mRNA and protein expression of the CoREST family
in neuronal maturation. CoREST1 protein levels were re-
duced, but RNA levels for Rcor1 remained similar through-
out differentiation (Sáez et al., 2015). In addition, CoREST1
protein levels were shown to increase during embryonic
development of the embryonic mouse reaching the highest
levels at postnatal days 0 and 15, followed by a reduction
in the aged mouse cortex (Fuentes et al., 2012). CoREST2
mRNA levels decreased during differentiation of both
PC12 cells and rat cortical neurons (Sáez et al., 2015).
Additionally, CoREST2 has been shown to be highly ex-
pressed in human and mouse ESCs (Yang et al., 2011),
and mRNA and protein widely expressed across most cell
types of the wild-type mouse cortex (Wang et al., 2016).
CoREST2 expression assessed by Western blot analysis
was shown to decrease in embryonic mice brains, indicat-
ing CoREST2 may function primarily during embryonic de-
velopment (Wang et al., 2016). Relative to CoREST1 and
CoREST2 significantly less is currently known about the
expression profile of CoREST3 during neurodevelopment.
Sáez et al. (2015) concluded that CoREST3 levels remain
unaltered during neuronal differentiation of both PC12
cells and rat cortical neurons. CoREST3 was also shown
to be expressed in rat hippocampal, cortical and whole
brain extracts via Western blot analysis (Sáez et al., 2015).
As the CoREST3 expression pattern remains to be defined,
knock-down and overexpression studies targeting RCOR3
will aid in identifying whether CoREST3 plays a role in regu-
lating neuronal differentiation. Collectively, this data indi-
cates a preliminary expression profile for the CoREST
family, suggesting CoREST1 and CoREST2 levels decrease
with maturation in certain brain regions, while CoREST3 ex-
pression remains unaltered in rat cortical neurogenesis. The
cell types used in each model may be responsible for the
variances observed in expression patterns. Further studies
focusing on the expression of each CoREST paralogue dur-
ing human neurodevelopment in different regions of the
brain will provide insight into the functions of the CoREST
family.
Differential subcellular localization of the CoREST family in
different cell types
CoREST1 and REST protein expression and localization
in different neuronal and glial subtypes were analyzed by
immunocytochemistry and Western blotting in primary
mouse neural cells (Abrajano et al., 2009a,b, 2010). Both
exhibited nuclear expression in NSCs and intermediate
progenitors, with expression in both the nucleus and cyto-
plasm of cholinergic, GABAergic, glutamatergic, and me-
dium spiny neuron subtypes (Abrajano et al., 2009a,
2010). In glial cells, both REST and CoREST1 were ex-
pressed ubiquitously in the nucleus or cytoplasm of astro-
cytes and oligodendrocytes (Abrajano et al., 2009b).
Immunohistochemistry of adult rat brain tissue revealed
CoREST1 and CoREST2 to be expressed in the nucleus
of both neurons and glial cells identified by colocalization
with b -III tubulin and GFAP, respectively (Sáez et al.,
2015). CoREST3 was identified to be expressed in hippo-
campal, cortical tissue and mouse glial culture, suggestive
of expression in both neurons and glia cell types (Sáez et
al., 2015). As CoREST3 expression was described to re-
main unchanged during differentiation it is unclear whether
the protein elicits a function. Identification of the subcellular
localization of the transcription factor will provide insight
into whether it is expressed in nucleus and may be poten-
tially regulating gene expression. Collectively, the expres-
sion of CoREST1 and CoREST2 predominantly in the
nucleus of both neural and glia cells is suggestive that they
may be repressing gene expression by binding to chroma-
tin in these cell types.
CoREST2 expression changes throughout cell division
CoREST2 was predominantly expressed in the nucleus
in cell types of the embryonic mouse brain, however, ex-
hibited diverse subcellular localization at different stages
of the cell cycle (Wang et al., 2016). Immunohistochemical
analysis showed CoREST2 in the nucleus of radial glia
cells during interphase and mainly localized in chromo-
somes during metaphase in the ventricular zone. During
anaphase, CoREST2 was partially translocated in the
space between two sets of separated chromosomes
(Wang et al., 2016). These findings reflect a similar pattern
to LSD1 during cell cycle progression in ESCs (Nair et al.,
2012). Taken together, these findings are indicative that
CoREST2 may be forming a transcriptional repressive
complex with LSD1 during interphase and repressing
genes required for cell division and maturation.
Collectively, the expression profile and subcellular lo-
calization of CoREST proteins suggest they have the po-
tential to regulate gene expression in both neuronal and
glial cell subtypes, however, further research is required
to confirm the same subcellular localization in human
cells and to identify the specific target genes being re-
pressed, further elucidating the functional roles of the
CoREST family. Taken together, these findings indicate
that the formation of multiple LCH complexes composed
of a different CoREST protein core would broaden the
genes targeted during neurodevelopment and may elicit
various functions across neural and glial cell populations.
CoREST proteins target unique genes compared with
REST
REST-mediated gene repression through the formation
of a complex with one of the CoREST proteins is expected
to target ;2000 RE1-site containing genes throughout
the human genome, many essential for neuronal develop-
ment (Bruce et al., 2004; Satoh et al., 2013). Research has
defined a mechanism for CoREST proteins to act as tran-
scriptional repressors independent to REST, targeting
many distinct genes responsible for the modulation of
neuronal and glial cell specification, maintenance, and
maturation (Abrajano et al., 2009a, b, 2010; Yu et al.,
2011). Genome-wide ChIP-seq in mouse ESCs investigat-
ing the binding of REST and its cofactors to sites on the
genome identified CoREST1 to have 84 peaks with 61
overlapping with REST, CoREST2 to have 459 genomic
binding sites and only 43 overlap with REST and
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CoREST3 to have 3744 peaks and 885 overlap with REST
(Yu et al., 2011). Further work is required to identify
whether the CoREST proteins binding directly to DNA, the
cofactors recruited to the genomic binding site and
whether the genes are functionally repressed by the activ-
ity of the complex. Through ChIP-on-chip analysis in
mouse NSCs, CoREST1 was shown to bind to a broader
range of genes (1820 genes) compared with REST (322
genes; Abrajano et al., 2010). Of these genes only 126
were targets of both REST and CoREST1. CoREST1 was
identified to target a significantly greater percentage of
genes involved in pluripotency such as NANOG/OCT4/
SOX2 network compared with REST (79 compared with
eight genes, respectively; Abrajano et al., 2010). Suggesting
CoREST1 has a widespread role in regulating NSC gene
networks that is unique to REST. Taken together, both
REST and CoREST1 play a role in regulating the switch be-
tween NSC self-renewal and neural lineage specification,
differentiation, and maturation. Among the genes targeted
by REST, 72% contain known RE1 sites, whereas only
41% genes targeted by CoREST1 contain known RE1
sites, indicating CoREST1 may repress transcription at ad-
ditional sites of DNA (Abrajano et al., 2010). In cholinergic,
GABAergic, glutamatergic and medium spiny neurons,
REST bound to 622, 587, 481, and 477 distinct genes, and
CoREST1 bound 600, 814, 266, and 967 unique target
genes, respectively (Abrajano et al., 2009a). Additionally,
3178 REST and 4060 CoREST1 target genes were
Table 1: Summary of characterized functional roles of the CoREST family in neurodevelopment
CoREST pro-
tein involved Functional role Species References
Regulation of
pluripotency
CoREST2 Rcor2 knock-down resulted in reduced proliferation and im-
paired pluripotency; the overexpression of CoREST2, to-
gether with Oct3/4, Klf4, c-Myc, was successfully used to
replace Sox2 in the generation of mouse and human in-
duced pluripotent stem cells
Mouse and
human
Yang et al.
(2011)
CoREST3 RCOR3 knock-down resulted in significant upregulation of
NANOG and enriched acetylated H3K9 residue on the
REST binding site in the NANOG promoter region; indi-
cating CoREST3 regulates NANOG expression through
the formation of a complex with REST and the deacetyla-
tion of the NANOG promoter region
Chicken Jung et al.
(2018)
Regulation of neu-
ronal differentia-
tion and
maturation
CoREST1 Rcor1 knock-down resulted in impaired radial migration of
cortical pyramidal neurons in the developing cerebral cor-
tex; Rcor1 knock-down cells exhibited delayed migration,
remained in the ventricular zone and expressed Sox2 and
Tbr2, suggesting the cells had not differentiated from pre-
cursor lineages
Mouse Fuentes et al.
(2012)
CoREST2 Rcor2 conditional knock-out (Rcor2cko) mice had signifi-
cantly reduced brain sizes, cortical thickness, and struc-
tural abnormalities of the brain layers; Rcor2cko mice had
reduced numbers of neuronal progenitors and neurons,
and increased cell death; the gene knock-out (KO) mice
showed significant upregulation of ventral markers and
decrease in cortical markers, suggesting CoREST2 regu-
lates the sonic hedgehog signaling pathway
Mouse Wang et al.
(2016)
CoREST1 and
CoREST2
The individual gene knock-out (KO) mice were indistinguish-
able to the control cohort, combined deletion resulted in
severe brain phenotypes and death; Rcor1/2 KO mice
had an increased population of proliferating cells, sug-
gesting these mice lacked the mechanism to differentiate
precursors into postmitotic neurons and mature oligoden-
drocytes; CoREST1 and CoREST2 are hypothesized to
elicit this function through the formation of a complex
with insulinoma-associated 1
Mouse Monaghan et
al. (2017)
Regulation of neu-
roinflammation
CoREST1 CoREST1 interacts with the promoter of hsp70, a gene that
encodes heat shock protein 70 (Hsp70); through this in-
teraction, CoREST1 represses both HSF1-dependent and
heat-shock-dependent transcriptional activation of
hsp70; RCOR1 knock-down resulted in loss of Hsp70 re-
pression, inducing the heat shock response
Human Gómez et al.
(2008)
CoREST2 Rcor2 expression was shown to decrease in an aging
mouse model, accompanied by an increase in proinflam-
matory markers; Rcor2 knock-down further increased in-
flammatory marker expression
Mouse Alvarez-
López et
al. (2014)
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observed in the two glial cell types, astrocytes and oligo-
dendrocytes (Abrajano et al., 2009b). REST bound to 287
genes specific to astrocytes and 1365 genes specific to oli-
godendrocytes. CoREST1 was identified to interact with
40 unique targets in astrocytes and 963 genes in oligo-
dendrocytes (Abrajano et al., 2009b). These studies have
shown that REST and CoREST1 have the potential to
regulate neuronal and glial differentiation, specification,
and maintenance via the genes they target. Overall,
these findings are suggestive that CoREST1 has a
broad, cell type-specific role in neurodevelopment that
is distinct and complementary to REST. The DNA se-
quence each CoREST paralogue targets, the complex
formed at these sites and the gene networks regulated
are yet to be defined. Further ChIP-on-chip studies with
high resolution whole-genome approaches in human tis-
sue will provide insight into the unique and interrelated
regulatory networks of REST and CoREST paralogues.
Functional roles of the CoREST family in
neurodevelopment
The molecular mechanisms governing normal develop-
ment of the brain are yet to be fully elucidated. The regula-
tion of gene expression by transcription factors plays a
significant role in the specification and maturation of neu-
rons. Of the three paralogues, CoREST1 has been the
most widely studied and is best understood for its role in
REST-mediated gene repression. However, recent evi-
dence has shown the CoREST paralogues interact with
LSD1 and HDAC1/2 independently of REST and contrib-
ute to gene repression (Barrios et al., 2014; Pilotto et al.,
2015; Wu et al., 2018). These studies have shifted our
understanding that CoREST family act solely as REST
corepressors but also have distinct and essential roles in
regulating neurodevelopment. The known functions of the
CoREST protein family in neurodevelopment is summar-
ized in Table 1. Current knowledge regarding the role of
the CoREST proteins has largely been based off animal
studies. Rockowitz and Zheng (2015) showed that REST
target sites do not completely overlap between human
and mouse genomes, with human ESCs having twice as
many REST sites as mouse ESCs via ChIP-seq analysis
(n=8199 vs n= 4107). From these findings it can be hy-
pothesized that there may also be differences in the
genes targeted by each CoREST protein between spe-
cies. Continued research focusing on the action of the
CoREST family will provide insight into the regulatory net-
works orchestrating neurodevelopment.
It is becoming evident that the CoREST family have
unique functions independent to REST, in addition to hav-
ing distinct roles for each paralogue. Monaghan et al.
(2017) showed that Rcor1/Rcor2 knock-out mice had se-
vere deficits in neuronal and glial cell differentiation and a
concomitant increase in Rest mRNA levels. Normalization
of Rest levels fully restored one of the seven targets that
was down regulated (Celsr3), the other transcripts were
only partially restored (Chrnb2, Trim67, and Unc13a)
whereas the remaining three were not rescued (Fam65b,
Gad2, and Scrt1). These results indicate that Rcor1 and
Rcor2 regulate the switch between proliferation and
differentiation in the developing mouse brain in a predom-
inantly Rest-independent manner. In addition, Fuentes et
al. (2012) showed Rcor1 knock-down resulted in impaired
radial migration of cortical pyramidal neurons in the devel-
oping mouse cortex. To confirm the phenotype was medi-
ated by CoREST1, the authors showed overexpression of
CoREST1 with a mutated N terminus, to hinder associa-
tion with Rest, could rescue the migration of neurons in
the cerebral cortex. In addition, shRNA knock-down of
Rest via electroporation at embryonic day 14 showed no
differences in migration when compared with control.
These results suggest that CoREST1 regulates pyramidal
neuron development independent to Rest in the develop-
ing mouse brain. The CoREST paralogues have been
shown to have distinct roles in the regulation of pluripo-
tency independent to each other. Overexpression of
RCOR2, but not RCOR1, was successful in the reprogram-
ming of induced pluripotent stem cells (Yang et al., 2011).
In chicken primordial germ cells, the knock-down of
RCOR3 resulted in the upregulation of the pluripotency
regulator NANOG, whereas siRNA knock-down of RCOR1
and other chromatin modifying enzymes known to form a
complex with REST showed no significant changes in
NANOG expression (Jung et al., 2018). Collectively, these
studies show that the CoREST family have critical roles
during neurodevelopment, that are independent to REST
and may have compensating or distinct functions to each
paralogue. Further ChIP-on-chip studies with high-resolu-
tion whole genome approaches are required to identify the
binding sites of each CoREST protein in conjunction with
knock-down and overexpression studies to identify the
specific pathways and networks regulated, and thus deep-
en our understanding of the epigenetic mechanisms that
govern neurodevelopment.
Our knowledge of the functional roles of the CoREST
protein family stems from a heavy reliance on animal
models, with the exemption of the study completed by
Yang et al. (2011) who was successful in overexpressing
RCOR2 to reprogram human stem cells and Gómez et al.
(2008) that investigated CoREST1-mediated regulation of
the heat shock response in the human embryonic kidney
cell line, HEK293. As previously stated, it has been shown
that the targets of REST do not overlap between species
(Rockowitz and Zheng, 2015), with the same hypothe-
sized for the CoREST paralogues. Thus, human models of
neurogenesis, such as human pluripotent stem cells,
should be employed to further interrogate the molecular
mechanisms regulated by the CoREST family.
The CoREST complex as a potential
target for therapeutics
Aberrant expression or subcellular localization of
REST contributes to the disruption of gene regulatory net-
works and is associated with the pathophysiology of neu-
rodegenerative conditions. It has been hypothesized that
targeting REST may help protect from the progression of
these conditions. For example, in Huntington’s disease
(HD), the accumulation of nuclear REST in medium
spiny neurons of the striatum results in enhanced repres-
sion of BDNF transcription contributing to an increased
Review 9 of 12
March/April 2020, 7(2) ENEURO.0337-19.2020 eNeuro.org
susceptibility to neuronal loss (Zuccato et al., 2003). A po-
tential therapeutic for HD pathogenesis is targeting splic-
ing of REST using antisense oligonucleotides in vitro to
reduce the accumulation of nuclear REST (Chen et al.,
2017). However, as REST targets the RE1 site in ;2000
genes in the human genome, the modulation of REST re-
mains a difficult target as it has the potential to have multi-
ple downstream effects. An alternative is to target the
LCH complex, for example, using corin, a derivative of a
synthesized compound derived from the HDAC1 inhibitor
(entinostat) and the LSD1 inhibitor (tranylcypromine ana-
logue) to simultaneously target both components of the
LCH complex (Kalin et al., 2018). The dual-hybrid agent
has been successfully used as a potential therapeutic in
cancer studies by reducing the proliferation of mouse
melanoma cells through blocking the active sites of
HDAC1 and LSD1 of the LCH complex (Kalin et al., 2018).
Synaptic dysfunction is a common in many neurodege-
nerative diseases including AD, with HDACs involved in
regulating synaptogenesis and synaptic plasticity (Fuller
et al., 2019). HDAC inhibitors have been trialed to improve
synaptic growth and function, but have been limited due
to their off-target effects and dose-limiting hematologic
toxicities. Fuller et al. (2019) used the CoREST-selective
HDAC inhibitor Rodin-A in a mouse model and were suc-
cessful in increasing spine density, expression of synaptic
proteins and long-term potentiation at suitable doses to
allow for chronic treatment. This study has shown that se-
lectively targeting the CoREST complex, and not the Sin3,
NCoR, and NuRD complexes, offers a promising thera-
peutic for synaptopathies and that the CoREST complex
is a key regulator of synaptic growth and function (Fuller
et al., 2019).
The regulatory mechanisms governing CoREST pro-
tein expression and function remain largely unknown.
Sáez et al. (2018) have described a possible mode of
regulation of the CoREST proteins via the interaction
with protein inhibitor of activated STAT (PIASy) and
SUMOylation which may control cell fate determination
during development. Abrajano et al. (2010) proposed a
mechanism in which CoREST1 regulates its own expres-
sion by binding to the gene Senp1, which encodes for a
small ubiquitin-like modifier (SUMO)-specific protease
and has been previously shown to inhibit CoREST1 ac-
tivity (Muraoka et al., 2008). Future investigation into the
regulatory networks of each CoREST paralogue will be
crucial in understanding the processes of neurodevelop-
ment and may provide potential therapeutic targets for
neurodegenerative conditions.
Summary
In summary, REST has been well documented for its
function in neuronal differentiation and maturation, with
new evidence emerging of a potential neuroprotective
role in neurodegeneration. More focus needs to be dedi-
cated to the CoREST family, as the importance of
CoREST-mediated gene repression during neurodevelop-
ment is continuing to grow in the field. It is clear that there
are differences in the target genes between CoREST1
and REST in different neuronal and glial cell types,
suggesting that each paralogue may play distinct and im-
portant roles in neurodevelopment. Future studies fo-
cused on the target genes, extensive expression profile
and regulatory networks of the CoREST paralogues in dif-
ferent human neural and glial cell types will deepen our
understanding of the tightly regulated molecular mecha-
nisms of neurogenesis and normal brain development.
It is clear that CoREST proteins are essential for proper
neurodevelopment and dysfunction of these regulatory
mechanisms are potentially linked to the progression of
neurodegenerative conditions. Therefore, the CoREST
family have a broader function outside of acting solely as
a REST corepressor but are also independent and critical
regulators of neurodevelopment.
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